Quantinuum Inc. (NASDAQ:QNT) Receives Average Recommendation of “Moderate Buy” from Analysts

Quantinuum Inc. (NASDAQ:QNT) has received a consensus recommendation of “Moderate Buy” from the fourteen research firms that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $98.4167.

A number of equities analysts have recently issued reports on QNT shares. Craig Hallum began coverage on Quantinuum in a report on Monday, June 29th. They issued a “buy” rating and a $100.00 target price for the company. TD Cowen assumed coverage on Quantinuum in a research report on Monday, June 29th. They issued a “buy” rating on the stock. Rosenblatt Securities reiterated a “buy” rating and set a $155.00 price objective on shares of Quantinuum in a research note on Wednesday, August 12th. Sanford C. Bernstein reissued a “hold” rating on shares of Quantinuum in a report on Wednesday, August 12th. Finally, Zacks Research upgraded shares of Quantinuum to a “hold” rating in a research note on Tuesday, June 30th.

Quantinuum Trading Up 3.8%

NASDAQ QNT opened at $66.01 on Tuesday. Quantinuum has a twelve month low of $47.06 and a twelve month high of $86.79. The company has a 50-day simple moving average of $63.35.

Quantinuum (NASDAQ:QNT) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The business had revenue of $8.00 million for the quarter. As a group, research analysts anticipate that Quantinuum will post -1.64 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Manish H. Bhatia acquired 20,000 shares of the company’s stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $60.00 per share, with a total value of $1,200,000.00. Following the completion of the acquisition, the director owned 25,833 shares in the company, valued at approximately $1,549,980. This represents a 342.88% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Hal Barron bought 250,000 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was purchased at an average price of $60.00 per share, with a total value of $15,000,000.00. Following the purchase, the director directly owned 255,833 shares of the company’s stock, valued at $15,349,980. The trade was a 4,285.96% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased a total of 411,032 shares of company stock worth $24,661,920 over the last ninety days.

Institutional Investors Weigh In On Quantinuum

A hedge fund recently bought a new position in Quantinuum stock. Lisanti Capital Growth LLC acquired a new stake in Quantinuum Inc. (NASDAQ:QNT) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 5,005 shares of the company’s stock, valued at approximately $409,000.

About Quantinuum

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.